04.11.2026
- Helse og life science
Oslo Economics is pleased to take part in ISPOR Europe 2026 in Vienna. Several of our colleagues will attend and present our recent work in health economics and related topics.
Presentation schedule
-
Tuesday10:30–13:30
The Limitations of EQ-5D-5L for Healthcare Decision Making: A Systematic Literature Review
-
Wednesday9:00–11:30
Cost-effectiveness analysis of rimegepant versus standard of care for preventive treatment of episodic migraine in Norway: The impact of productivity gains
Posters
Poster
The Limitations of EQ-5D-5L for Healthcare Decision Making: A Systematic Literature Review
Available 11 November
Poster
Cost-effectiveness analysis of rimegepant versus standard of care for preventive treatment of episodic migraine in Norway: The impact of productivity gains
Available 11 November
Our representatives
Christoffer Bugge
Partner
Francisco Oteiza
Senior Manager
Maren Gillebo
Senior Economist
Mie Hustad
Economist
Selma Conradi Melsom
Economist
Questions? Please contact Christoffer Bugge.
